Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Molecular and Cellular Biology
|
December 3, 2003
Characterization of Sleeping Beauty transposition and its application to genetic screening in mice
Kyoji Horie, Kosuke Yusa, Kojiro Yae, et al.
Sarcoma
|
January 16, 2013
Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST
Vincent W Keng, Adrienne L Watson, Eric P Rahrmann, et al.
Hepatology (Baltimore, Md.)
|
April 26, 2008
A facile method for somatic, lifelong manipulation of multiple genes in the mouse liver
Kirk J Wangensteen, Andrew Wilber, Vincent W Keng, et al.
Oncotarget
|
April 1, 2014
Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity
Adrienne L Watson, Leah K Anderson, Andrew D Greeley, et al.
Biochemical and Biophysical Research Communications
|
August 13, 2020
Schwann cell-specific Pten inactivation reveals essential role of the sympathetic nervous system activity in adipose tissue development
Xiao-Xiao Li, Shi-Jie Zhang, Ka-Yi Man, et al.
Plos Genetics
|
April 18, 2013
Identification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesis
Jesse D Riordan, Vincent W Keng, Barbara R Tschida, et al.
Nature Genetics
|
May 21, 2013
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis
Eric P Rahrmann, Adrienne L Watson, Vincent W Keng, et al.
JHEP Reports : Innovation in Hepatology
|
February 19, 2021
ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis
Jeffrey C To, Amy P Chiu, Barbara R Tschida, et al.
Cancer Research
|
April 27, 2021
EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma
Hoi Wing Leung, Carmen Oi Ning Leung, Eunice Y Lau, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 5, 2012
A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer
Kathryn A O'Donnell, Vincent W Keng, Brian York, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Molecular and Cellular Biology
|
December 3, 2003
Characterization of Sleeping Beauty transposition and its application to genetic screening in mice
Kyoji Horie, Kosuke Yusa, Kojiro Yae, et al.
Sarcoma
|
January 16, 2013
Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST
Vincent W Keng, Adrienne L Watson, Eric P Rahrmann, et al.
Hepatology (Baltimore, Md.)
|
April 26, 2008
A facile method for somatic, lifelong manipulation of multiple genes in the mouse liver
Kirk J Wangensteen, Andrew Wilber, Vincent W Keng, et al.
Oncotarget
|
April 1, 2014
Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity
Adrienne L Watson, Leah K Anderson, Andrew D Greeley, et al.
Biochemical and Biophysical Research Communications
|
August 13, 2020
Schwann cell-specific Pten inactivation reveals essential role of the sympathetic nervous system activity in adipose tissue development
Xiao-Xiao Li, Shi-Jie Zhang, Ka-Yi Man, et al.
Plos Genetics
|
April 18, 2013
Identification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesis
Jesse D Riordan, Vincent W Keng, Barbara R Tschida, et al.
Nature Genetics
|
May 21, 2013
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis
Eric P Rahrmann, Adrienne L Watson, Vincent W Keng, et al.
JHEP Reports : Innovation in Hepatology
|
February 19, 2021
ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis
Jeffrey C To, Amy P Chiu, Barbara R Tschida, et al.
Cancer Research
|
April 27, 2021
EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma
Hoi Wing Leung, Carmen Oi Ning Leung, Eunice Y Lau, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 5, 2012
A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer
Kathryn A O'Donnell, Vincent W Keng, Brian York, et al.
Page
of 5